Ten year follow-up of healthy children who received one or two injections of varicella vaccine. - Wikidata - wikimedia - TriplyDB

Ten year follow-up of healthy children who received one or two injections of varicella vaccine.

Ten year follow-up of healthy children who received one or two injections of varicella vaccine.

http://www.wikidata.org/entity/Q44793181

about

Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults Microbiology laboratory and the management of mother-child varicella-zoster virus infection Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial.Varicella vaccination in Europe - taking the practical approach.Impact of varicella vaccine on varicella-zoster virus dynamics Preventing varicella-zoster disease An outbreak of varicella among schoolchildren in Taipei.Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses Herpes zoster vaccine for the elderly: boosting immunity.Successes and challenges in varicella vaccine First reported cluster of overwhelming group A streptococcal septicaemia and associated chickenpox infection in the UK Effectiveness of 2 doses of varicella vaccine in children.Impact of 2-dose vaccination on varicella epidemiology: Connecticut--2005-2008 Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011 Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses Impact of the US Two-dose Varicella Vaccination Program on the Epidemiology of Varicella Outbreaks: Data from Nine States, 2005-2012.Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster Varicella-zoster vaccine in the USA: success for control of disease severity, but what next?Single-dose varicella vaccine effectiveness in school settings in China.A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China.Impact of a routine two-dose varicella vaccination program on varicella epidemiology.Antibody induced by one-dose varicella vaccine soon became weak in children: evidence from a cross-sectional seroepidemiological survey in Beijing, PRC Review of the Varilrix varicella vaccine.Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.Successes and remaining challenges after 10 years of varicella vaccination in the USA.Asthma and risk of breakthrough varicella infection in children.Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMV Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.An Evaluation of Voluntary Varicella Vaccination Coverage in Zhejiang Province, East China.Primary vaccine failure after 1 dose of varicella vaccine in healthy children.Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination Varicella vaccine effectiveness in the US vaccination program: a review.Immunization issues in pediatric travelers.Issues in pediatric vaccine-preventable diseases in low- to middle-income countries Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs.

P2860

Q24193819-29A81194-47A6-4349-AFCC-6DD07D259ACE Q24242809-350EC62C-88FA-42C5-BFFC-995E7FFC181A Q26738745-33764612-3576-4902-A4C0-A3080AD00D18 Q30701352-A2F9466A-0F92-4A53-9399-1A31DB419198 Q33430135-78763D59-ABD9-4AEC-9558-C4C2606C82A7 Q33454919-6048AE66-9D63-40CF-BB63-4F61A2294982 Q33591264-7C928440-44DE-4B8B-A595-5228BDA79CEA Q33719386-C3CB19C7-2339-4A18-B9EB-F89B3C9CA85C Q33870506-5A2607D9-CE45-4FCD-AF30-439433CA783E Q33880341-017A42D3-BFB3-442C-9537-B20241ABE62C Q33956779-4E4F8C88-DC98-4D32-AE14-BF7865E3C138 Q34416710-B582D640-6D59-4007-8752-16CFDDEC1364 Q34535708-17AF990F-19F9-46DC-922E-4F4B745D1ECA Q34763888-5E3A5F88-8CBA-4FBE-AD31-9BB91A89ACD4 Q34764434-63DDDB10-5FEE-403D-BFCC-01FC24C2CC19 Q34788015-5F1F19C1-18C1-4018-A56F-96C2E1E676A6 Q35105463-F3AF6596-86E7-4289-AF49-1AFC6656A816 Q35694421-C5AF62FE-5D34-4040-8223-7CB4934D2FA1 Q35887597-07E92EDD-0EC5-40E2-BFEA-D3C2B092AA8D Q35942988-83703965-6048-4BD8-B71D-92F911465FC3 Q36066227-9F608BA1-DC68-4454-A288-3556414C1987 Q36161043-A254B77B-3BF5-4101-8643-1F010C016C6D Q36205742-436DC956-BEAE-428A-BAC1-382A83340BD1 Q36206514-EE6849CC-6C0D-45A1-BFED-160D0C158ED2 Q36270547-F15CADFD-B335-4EA3-8F62-6B3455317D25 Q36284539-419A3C6D-D4A0-40F9-B078-F40FCDE727AC Q36358276-B76B45AB-99BB-4B55-BB29-51D36652887A Q36369132-18BB2A00-CE6C-406F-B6EA-B3DDD8AFC083 Q36445564-B9B11AED-74D0-443B-A0D1-8BAC2F120B46 Q36841455-28FB9E4E-BF9A-4F6E-812E-30FA85ABA741 Q36887989-2E9D28B0-00A8-444B-B99D-09693817C29C Q36897967-39C2139E-94C7-40AD-9416-6D846CCAC389 Q36951972-9947A36E-107E-48F2-8B59-5936873A3443 Q37044741-A6509EA3-BF6D-4CCD-94CC-8B40E50B7E4B Q37131910-9FA5EA83-2BD0-419B-99CD-3E86E70A68F4 Q37135445-F564822A-246F-4536-9452-394C8E7910B8 Q37141186-0AD8F72C-C26A-4F3E-AE3F-E36981713CC5 Q37194794-7B00B4B5-7C5C-457B-9859-92A01E5D0661 Q37264972-53C2BF41-6388-4BED-882A-8957043B2904 Q37283124-201F67F9-7591-4D4F-9F5D-03AD92D62D3F

P2860

Ten year follow-up of healthy children who received one or two injections of varicella vaccine.

http://www.wikidata.org/entity/Q44793181

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Ten year follow-up of healthy ...... jections of varicella vaccine.

@en

Ten year follow-up of healthy ...... jections of varicella vaccine.

@nl

type

label

Ten year follow-up of healthy ...... jections of varicella vaccine.

@en

Ten year follow-up of healthy ...... jections of varicella vaccine.

@nl

prefLabel

Ten year follow-up of healthy ...... jections of varicella vaccine.

@en

Ten year follow-up of healthy ...... jections of varicella vaccine.

@nl

P1433

Q44793181-F8496C0E-B81F-41ED-9F48-DC2C28272C22

P1476

Q44793181-922917F5-2A88-43EE-B3B0-8DD4E352DB08

P2093

Q44793181-1D9D5B65-1E9D-4FE7-B322-0A3DE08B0652

Q44793181-45974324-27D9-40D8-BC3F-29A1A5304AD7

Q44793181-4CBE67BC-71C7-468C-9089-432EA82ED6CD

Q44793181-62D5A92D-649C-4EE5-8D8B-3BA0F6B201D6

Q44793181-6B975FF1-6EF4-4E08-938C-2B814884CBB4

Q44793181-6C88894C-2641-483E-9352-BF032544B566

Q44793181-75AFF4F5-CD1E-462F-B7EB-9A341C9D111F

Q44793181-A8BB027B-75AF-40D3-8FC2-5881171F490D

Q44793181-DAEB3A19-E0B1-4666-A58D-9519897E5D03

Q44793181-E22D0016-87E0-4DB0-928B-DFF2C21354A6

P304

Q44793181-8C8E85AA-68E2-48E8-85D8-56A13E516239

P31

Q44793181-4A99C556-7C4A-40E9-84FF-270BC3BE7D03

P356

Q44793181-9D5E2E25-C095-488A-BFB4-457F7A7B49EC

P433

Q44793181-96D71D76-DFA2-48A8-9AAC-7248E7A03FFA

P478

Q44793181-4035D4A7-81D4-4A1F-A6D2-D59314C88160

P50

Q44793181-79CB4E6E-0D99-417F-822A-9E52EE0BB24F

P577

Q44793181-E818AA14-180A-4E61-8FB4-883937B86BD2

P698

Q44793181-CB483DC1-B84B-49D1-9F5E-0ADC9C06BC94

P356

01.INF.0000109287.97518.67

P1433

Pediatric Infectious Disease Journal

P1476

Ten year follow-up of healthy ...... jections of varicella vaccine.

@en

P2093

Barbara Kuter

http://www.w3.org/2001/XMLSchema#string

Barbara Watson

http://www.w3.org/2001/XMLSchema#string

Henry Shinefield

http://www.w3.org/2001/XMLSchema#string

Holly Matthews

http://www.w3.org/2001/XMLSchema#string

Ivan Chan

http://www.w3.org/2001/XMLSchema#string

Jonathan Hartzel

http://www.w3.org/2001/XMLSchema#string

Keith Reisinger

http://www.w3.org/2001/XMLSchema#string

Lee Lian Kim

http://www.w3.org/2001/XMLSchema#string

Lisa Lupinacci

http://www.w3.org/2001/XMLSchema#string

Steve Black

http://www.w3.org/2001/XMLSchema#string

P304

132-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.INF.0000109287.97518.67

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Penelope H. Dennehy

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14872179

http://www.w3.org/2001/XMLSchema#string